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ABSTRACT: Mycoplasmas, the simplest self-replicating organisms known, are distinguished phenotypically
from other bacteria by their minute size and total lack of cell wall. The poultry industry is affected by several
species of mycoplasmas, but Mycoplasma gallisepticum (MG) is the most economically significant one. The
attachment of mycoplasmas to host respiratory epithelial cells constitutes a critical step in the pathway leading
to infection and disease and is achieved by lipoproteins localized on the bacterial surface. In a recent in silico
study, it was predicted a set of MG putative surface proteins with potential antigenic properties that could be
used as candidates for exploring new vaccines, and for diagnostic tests as well. One of those potential candidates
was the OppA. In this work we described the molecular cloning of the DNA segment that encodes a fragment
of OppA, a polypeptide of 233 aa and about 30 kDa, as well as its expression, purification and immunogenic
response induced by the product obtained.
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Clonaje molecular y expresión de un antígeno de superficie de Mycoplasma gallisepticum,
predicho computacionalmente
RESUMEN: Los micoplasmas son los organismos autoreplicativos más simples que se conocen, y que se
distinguen de otras bacterias por su pequeña talla y la total carencia de pared celular. La industria avícola está
afectada por varias especies de micoplasmas, pero Mycoplasma gallisepticum (MG) es el más significativo
económicamente. La adherencia de los micoplasmas a las células epiteliales respiratorias del huésped, constituye
un paso crítico en el camino que lleva a la infección y a la enfermedad, y se realiza mediante lipoproteínas
localizadas en la superficie de la bacteria. En un estudio reciente in silico, se predijo la existencia de un grupo
de posibles proteínas de superficie con potenciales propiedades antigénicas que podrían ser usadas como
candidatas para explorar nuevas vacunas, así como pruebas diagnósticas. Uno de estos candidatos fue OppA.
En este trabajo se describe el clonaje molecular de un segmento que codifica para un fragmento de OppA, un
polipéptido de 233 aa y aproximadamente 30kDa, así como su expresión, purificación y la respuesta
inmunogénica inducida por el producto obtenido.
Palabras clave: Mycoplasma gallisepticum, proteína de superficie, proteína recombinante, purificación por IMAC.
INTRODUCTION
Mycoplasmas, the simplest self-replicating
organisms known, are distinguished phenotypically from
other bacteria by their minute size and total lack of cell
wall, characteristics derived from the degenerative
(reductive) evolution from their gram-positive bacterial
ancestors (1).
Despite their genetic simplicity, mycoplasmas are
considered to be major animal and plant pathogens
worldwide. The poultry industry is affected by several
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species of mycoplasmas. Of these, Mycoplasma
gallisepticum (MG) is the most economically significant.
The chronic respiratory disease caused by this infection
represents serious problems. Although this disease
does not necessarily account for high mortality,
morbidity is high, and the consequent damaging effects
of the  disease are due to lowered egg production,
retarded growth, poor carcass quality and predisposition
to secondary viral and bacterial infections (2). Valuable
breeding flocks that become infected may well be
slaughtered or may lose the export market for their
progeny (3).
The attachment of mycoplasmas to host respiratory
epithelial cells constitutes a critical step in the pathway
leading to infection and disease (4), and is achieved by
lipoproteins localized on their surface. Due to the lack
of cell wall and surface appendages common to other
eubacteria, the mycoplasma membrane proteins are
directly involved in mycoplasma-host interaction and
play a crucial role in mycoplasma pathogenesis. The
critical role of citadherence in virulence is reflected by
the inability of noncytadhering MG strains to cause
disease in experimentally infected animals (5). Although
the adhesins play the major role in cytadhesion, the
process also involves accessory membrane proteins.
Data emerging from recent studies indicate that,
although some putative cytadhesins like VlhA family
(6), GapA (7), PvpA (8) or cytadhesin-related molecules
like CrmA (9) from MG  have been reported, several of
them  have yet to be identified, defined and
characterized, a step which is crucial to understand
the exact contribution of each of these proteins in
promoting and maintaining a successful infection in the
avian host.
Recently, in a bioinformatic study carried out in our
laboratory, a fragment of OppA protein
(locus_tag="MGA_0237") that encodes a polypeptide
of 233 aa of about 30 kDa, was predicted as MG putative
surface polypeptide with potential antigenic properties.
Since they are in direct contact with the environment
and, specifically, with the host immune system, surface
localized virulence factors such as adhesins, serve as
excellent immunogenic candidates (10). In this regard,
this protein could be used as a candidate for exploring
new vaccines and diagnostic systems.
In this work, we describe the molecular cloning of
the DNA segment that codifies for this fragment, as
well as its expression, purification and immunogenic
capacity of the product obtained.
MATERIALS AND METHODS
Vectors, bacterial strains and growth conditions
The Top 10 F’ and BL21-CodonPlus(DE3)-RIL cells
were obtained from the strain bank of the Centre for
Genetic Engineering and Biotechnology (CIGB) (La
Habana, Cuba). The MG strain R was donated by Dr.
Konrad Sachse (Friedrich-Loeffler-Institut, Fed. Res.
Ctr. for Animal Health, Jena, Germany). Top 10 F’
competent cells were transformed with pQE30 plasmid
and grown O/N at 37°C in Luria-Bertani (LB) medium
supplemented with 100μg of ampicillin/ml (Promega).
Vector Preparation
The pQE30 plasmid (QIAGEN) was purified using
the AccuPrepTM Plasmid Extraction Kit, spin column
(Hylabs). Five micrograms of the vector were digested
with 50U each of Sac I and Kpn I (all the reagents from
Promega) in 100μl of total volume and in presence of
0.1mg/ml BSA and 10μl of MULTI-CORETM buffer; the
digestion was carried out for 3 hours at 37°C. The
digested product was applied on a 0.8% (w/v) low-
melting point agarose gel, from where, after
electrophoresis,  a 3455bp band corresponding to the
digested pQE30 plasmid was isolated. This band was
purified using the AccuPrep® Gel Purification Kit
(Hylabs).
When kits were used all the procedures were carried
out according to the manufacturer’s instructions.
Obtainment and preparation of PCR products
The gene fragment was obtained by PCR using MG
strain R chromosomal DNA as template and Pwo
polymerase (CIGB) in a total volume of 50μl reaction.
All the PCR conditions were adjusted according to the
primer melting temperatures and PCR fragment length.
The primers were designed in such a way that Sac I
and Kpn I restriction sites were additionally introduced
in the extremes 5´and 3´ of the PCR product for its
subsequent, in frame, cloning in the expression vector
pQE30. The final PCR product was purified by
AccuPrep® PCR Purification Kit, spin column (Hylabs).
Five micrograms of the PCR product were digested
with 50U each of Sac I and Kpn I (Promega) in 100μl of
total volume and in presence of 0.1mg/ml BSA and
10μl of MULTI-CORETM buffer; the digestion was carried
out for 3 hours at 37°C. The digested product was purified
by AccuPrep® PCR Purification Kit, spin column
(Hylabs).
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Recombinant plasmid generation
To obtain the recombinant construction, the previously
digested gene fragment and pQE30 (Qiagen) vector were
ligated; 4U of T4 DNA Ligase (Promega), 2μl T4 DNA
Ligase buffer 10x (Promega) were used in a total 20μl
volume and the reaction was carried out at 22°C for 5h.
For transformation, Ca2+ competent cells from Top
10 F’ of E. coli (CIGB) were used. They were
transformed as follows: 10μl of the ligation product were
added to 150μl of competent cells, the mix was
incubated in ice for 20 min, then, 45 sec at 42°C and,
to finish, again in ice for 5 min; 1ml of LB medium was
added to the mix and this was incubated for 1h at 37°C
at 50rpm. LB plates supplemented with 100μg of
ampicillin/ml were inoculated with this culture and
incubated O/N at 37°C.
The screening of recombinant clones was done by
PCR with the same primers used for obtaining the
fragment.
BL21-CodonPlus(DE3)-RIL competent cells (CIGB)
were transformed with the recombinant plasmid
following the same protocol used for transforming the
Ca2+ competent cells from Top 10 F’.
Expression of recombinant fragments
For expression experiments, the method of
autoinduction developed by Studier (13) with some
modifications was used. E. coli BL21-CodonPlus
(DE3)-RIL cells (CIGB) harboring the expression
constructs were cultured O/N at 37°C in a Luria-Bertani
broth supplemented with 50μg of kanamycin/ml. Next
day, 100ml (in a 1l erlenmeyer) of auto-induction me-
dia (1% Tryptone; 0.5% Yeast extract; 25mM
Na2HPO4; 25mM KH2PO4; 50mM NH4Cl; 5mM Na2SO4;
0.5% glycerol; 0.05% glucose; 0.2% alfa-lactose
monohydrate; 2mM MgSO4 heptahydrate; 0.05mM
FeCl3) supplemented with 100μg of ampicillin/ml
(Sigma) were inoculated with 10μl of the O/N inoculum
and grown for 16 hours with shaking of 310rpm. The
cells were harvested by centrifugation at 5,000 x g for
10 min and conserved at -20°C.
Recombinant protein isolation
Cell pellets were resuspended in PBS and lysis
carried out in a French press. The lysates were
centrifuged at 5,000 x g for 10 min and the pellet treated
with 8M urea for 3 hours at room temperature for protein
solubilisation. The isolated soluble proteins were
obtained by centrifugation at 10,000 x g for 30 min.
Polyclonal antibody production in rabbits
Two rabbits were immunized according to the
following schema: immunization with 200μg
subcutaneous in Complete Freund’s Adjuvant (CFA)
(Sigma); day 14, 100μg intradermal in Incomplete
Freund’s Adjuvant (IFA) (Sigma); day 28, 100μg
subcutaneous with IFA; day 56, 50μg subcutaneous in
IFA.
Rabbit polyclonal sera evaluation against
recombinant proteins
Both rabbit polyclonal preimmune and postimmune
sera, were evaluated by indirect ELISA; 1 μg of
recombinant protein was immobilized in plates
(MaxiSorp, NUNC) for 3h at 37ºC. Plates were blocked
with BSA (SIGMA) 1% for 1h at 37ºC. Antibodies were
diluted 1:1000, antirabbit-HRP (Sigma) conjugate 1:5000
and both assayed for 1h at 37ºC.
SDS-PAGE and Western blot
Briefly, SDS-PAGE was performed at constant
current of 30mA on a 15% acrylamide gels. The proteins
were analyzed either through staining with Coomassie
Blue or by using Western blotting. For Western blots,
the proteins were transferred to nitrocellulose
membranes using a semi-dry transfer equipment. The
membranes were blocked with 1% PBS-BSA for 1 hour.
The blots were probed for 2 hours at 37°C, with rabbit
recombinant protein antisera from experimentally
infected rabbits. Bound antibodies were detected by
using horseradish peroxidase (HRP)-conjugated anti-
rabbit IgG antibodies (Sigma) and 4-chloro-1- naphthol-
H2O2 substrate Kit (Bio-Rad), according to the
manufacturer’s instructions.
RESULTS AND DISCUSSION
The goal of this study was to obtain a recombinant
fragment of the OppA, previously predicted in our
laboratory, as a putative surface protein and to evaluate
its immunogenic properties. Interestingly, an
homologous of this protein in Mycoplasma hominis, has
shown to play an important role in the pathogenesis of
this bacterium (11, 12).
The 859 bp band corresponding to the oppA gene
fragment was successfully obtained from MG strain R
chromosomal DNA by PCR (Figure 1).
The oppA gene fragment was isolated from the PCR
mixture and cloned into pQE30 vector using the Kpn I
and Sac I restriction sites introduced into the amplified
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gene. One positive recombinant clone was detected
by PCR analysis (Figure 2).The initial transformation
was done in Top10-F’ cells of E. coli because this strain
facilitated the propagation and subsequent purification
of plasmids, but for the expression, it was necessary
to transform BL21(DE3) cells of E. coli with the
recombinant plasmids in order to guarantee a greater
control of the gene expression and a high level of it. In
pQE plasmids, the gene expression is under the con-
trol of the T7 RNA polymerase. This enzyme is so
specific, active, and processive that the amount of target
RNA produced can be comparable to the amount of
ribosomal RNA in a cell. A problem in using inducible
T7 expression systems is that T7 RNA polymerase is
so active that a small basal level can lead to a substantial
expression of the target protein even in the absence of
an inducer.
If the target protein is sufficiently toxic to the host
cell, establishment of the target plasmid in the
expression host may be difficult or impossible, or the
expression strain may be unstable or accumulate
mutations. In the BL21(DE3)-pQE system this problem
is overcome, the lac operator sequence (the binding
site for lac repressor) is placed in both, the start site of
a T7 promoter (of the pET plasmid) and in the lac
promoter, under the control of which is the T7 RNA
polymerase in the genome of cells. In this way, the
basal level of the target protein in uninduced cells is
substantially reduced, but induction leads to the typical
high levels of expression.
The obtained BL21(DE3) clones from the original
recombinant plasmids were thus designated pQE30-
oppA. This clone was then used for the expression of
the recombinant fragment of the OppA protein by using
the auto-induction method described by Studier (13).
Auto-induction allows efficient screening of many
clones in parallel for expression and solubility as
cultures have only to be inoculated and grown to
saturation, and yields of target protein are typically
several folds higher than those obtained by
conventional IPTG induction. In addition, IPTG, a very
expensive reagent, is substituted by the cheaper α-
lactose. In this system, lactose is used as inductor,
and the unintended level of expression of the target
protein in the initial moments of the culture is abolish
by the addition of glucose to the media. Glucose
prevents induction by lactose by well-studied
mechanisms. In the original protocol, expression
strains are grown O/N to saturation in non-inducing
media, which is then inoculated into the autoinduction
media (13). We substituted this non-inducing media
by the normal LB because in our hands the yields
were similar and the LB media was easier to prepare
(14).
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FIGURE 1. Agarose gel electrophoresis (0.8%) of PCR
products from Mycoplasma gallisepticum  strain R DNA.
Lines: 1, 2, 3 and 4: oppA PCR products; line 5: Negative
control./ Electroforesis en gel de agarosa (0.8%) de los
productos de PCR  a partir del ADN de la cepa R de
Mycoplasma gallisepticum. Líneas: 1, 2, 3 y 4: Productos
de PCR de oppA; línea 5: Control negativo.
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FIGURE 2. Agarose gel electrophoresis (0.8% ) of screening
of recombinant clones. Lines 1, 2 and 3: Clones 36, 103 and
104 of pQE_0237; line 4: Clone 105;  line 5: Negative control
of reaction; line 6: Clone pQE30 (negative control of vector);
line 7: Positive control of MGA_0237 fragment PCR product./
Electroforesis en gel de agarosa (0.8%) del monitoreo de
los clones recombinantes. Líneas: 1, 2, y 3: Clones 16, 103
y 104 del pQE30-0237; línea 4: Clon 105; línea 5: Con-
trol negativo de la reacción; línea 6: Clon pQE30 (con-
trol negativo del vector); línea 7: Control positivo del
producto de PCR del fragmento de MGA_0237.
















The SDS-PAGE analysis showed the expression
of a 30kDa protein fragment. The same expression
level was obtained for all the clones tested. From this
point, we decided to continue working only with one
of the clones, and for  further analyses we named it
pQE30-0237.
The expression of the OppA fragment for further
purification steps was also done by the autoinduction
method. The isolation of the OppA protein fragment was
a simple process, facilitated by the expression in an
insoluble form. The pellets were dissolved in 8M urea
and, in these conditions, the solubilisation of the protein
was achieved and it was obtained with a high level of
purity (Fig. 3).
For the evaluation of the immunogenic properties of
the OppA fragment protein, two female rabbits were
immunized. Both animals developed specific immune
response against OppA fragment protein (Fig. 4) as
shown by the ELISA analysis. No antibodies were
detected in the sera of the animal before immunizations
[S(-)] and either was detected any recognition signal of
E. coli proteins by sera of immunized rabbits [S(+)].
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FIGURE 3. Protein expression after lactose-autoinduction.
10% SDS-PAGE of total cells and isolated proteins.  Line 1:
pQE30-0237; line 2: pQE30; line 3:  isolated protein./ Expre-
sión de proteínas después de la autoinducción con lactosa.
SDS-PAGR al 10% de células totales y proteínas aisladas.
Línea 1: pQE30-0237; línea 2: pQE30; línea 3: proteína
aislada.
FIGURE 4. Evaluation of immune response elicits against OppA recombinant protein fragment. ELISA with the sera obtained
from immunized rabbits. It could be noted there is no significant antibody response again E.coli proteins./ Evaluación de
la respuesta inmune inducida contra el fragmento de la proteína recombinante OppA. ELISA con el suero obtenido de
conejos inmunizados. Cabe notar que no hay una respuesta significativa de anticuerpos contra las proteínas de E. coli.
CONCLUSIONS
As conclusions of this work, we can say that the in
silico predicted MG polypeptide OppA is immunogenic
in rabbits.
The described methodology will permit us to count
with large quantities of OppA antigen fragment, which
could facilitate the further studies of the subcellular
location of this protein and evaluate its role on MG
pathogenesis mechanisms.
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The potential surface localization of this protein, its
already proved immunogenicity, and the involvement of
its homolog from Mycoplasma hominis in virulence
mechanisms of this mycoplasma, make it a good
candidate to be tested in studies for vaccine
development or diagnostic systems.
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